| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.54 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.47 | 0.09 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.35 | 0.04 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.3 | 0.05 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |